Minimally Invasive Therapies Covidien Products Wound Closure Barbed Sutures

Overview

Secure. Fast. Effective.([FOOTNOTE=Alessandri F, Remorgida V, Venturini PL, Ferrero S, et al. Unidirectional barbed suture versus continuous suture with intracorporeal knots in laparoscopic myomectomy: a randomized study. J Minim Invasive Gynecol. 2010;17(6):725-729.],[ANCHOR=],[LINK=]),([FOOTNOTE=Rubin JP, Hunstad JP, Polynice A, Gusenoff JA, et al. A multicenter randomized controlled trial comparing absorbable barbed sutures versus conventional absorbable sutures for dermal closure in open surgical procedures. Aesthet Surg J. 2014;34(2):272-283.],[ANCHOR=],[LINK=])

The V-Loc™ wound closure device is a revolutionary technology that eliminates the need to tie knots, so you can close incisions up to 50% faster without compromising strength and security.1,2

Its dual-angle barbs allow suture to pass smoothly through tissue in one direction — but prevent it from slipping back through soft tissue.

The barbs hold wound surfaces together and distribute tension along the entire length of the suture, without needing knots to secure the wound.

Designed for secure, fast, and effective3,4 incision closure for your patients.

Explore the Product Catalog

Find product codes and sizes for all V-Loc™ device options.

View Catalog

See How to Use the Device

Discover the difference with V-Loc™ wound closure.

View Guide
PRODUCT INFORMATION
  V-Loc™ PBT wound closure device V-Loc™ 90 wound closure device V-Loc™ 180 wound closure device
Structure Unidirectional barbed monofilament Unidirectional barbed monofilament Unidirectional barbed monofilament
Suture Type Permanent Short-Term Absorbable Long-Term Absorbable
Composition Polybutester Synthetic polyester composed of glycolide, dioxanone and trimethylene carbonate Polyglyconate Copolymer of glycolic acid and trimethylene carbonate
Coating - Glycolide, Caprolactone and Calcium Stearoyl Lactylate -
Color  Blue Violet, Clear Green, Clear
Tensile Strength Permanent

7 days, 90%

14 days, 75%

7 days, 80%

14 days, 75%

21 days, 65%
Absorption Profile Permanent 90 – 110 days 180 days
Sizes 3-0, 2-0, 0, 1 4-0, 3-0, 2-0 4-0, 3-0, 2-0, 0
Indications V-Loc™ PBT non-absorbable wound closure devices are indicated for soft tissue approximation. V-Loc™ 90 absorbable wound closure devices are indicated for soft tissue approximation where use of an absorbable suture is appropriate. V-Loc™ 180 absorbable wound closure devices are indicated for soft tissue approximation where use of an absorbable suture is appropriate.
Contraindications The use of the V-Loc™ PBT nonabsorbable wound closure device is contraindicated in patients with known sensitivities or allergiesThe use of the V-Loc™ PBT nonabsorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. V-Loc™ PBT nonabsorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ PBT nonabsorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ PBT nonabsorbable wound closure device should not be used for ligating vessels or luminal structures. The use of the V-Loc™ 90 absorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. The V-Loc™ 90 absorbable wound closure device is not for use where prolonged (beyond 2 weeks) approximation of tissues under stress is required or for fixation of permanent cardiovascular prostheses or synthetic grafts. V-Loc™ 90 absorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ 90 absorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ 90 absorbable wound closure device should not be used for ligating vessels or luminal structures. The use of the V-Loc™ 180 absorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. The V-Loc™ 180 absorbable wound closure device is not for use where prolonged (beyond 3 weeks) approximation of tissues under stress is required or for fixation of permanent cardiovascular prostheses or synthetic grafts. V-Loc™ 180 absorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ 180 absorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ 180 absorbable wound closure device should not be used for ligating vessels or luminal structures.
Box Quantities 1 dozen 1 dozen 1 dozen

ORDER INFORMATION

codes beginning with:

 VLOCN VLOCM VLOCL
PRODUCT INFORMATION
  V-Loc™ PBT wound closure device V-Loc™ 90 wound closure device V-Loc™ 180 wound closure device
Structure Unidirectional barbed monofilament Unidirectional barbed monofilament Unidirectional barbed monofilament
Suture Type Permanent Short-Term Absorbable Long-Term Absorbable
Composition Polybutester Synthetic polyester composed of glycolide, dioxanone and trimethylene carbonate Polyglyconate Copolymer of glycolic acid and trimethylene carbonate
Coating - Glycolide, Caprolactone and Calcium Stearoyl Lactylate -
Color  Blue Violet, Clear Green, Clear
Tensile Strength Permanent

7 days, 90%

14 days, 75%

7 days, 80%

14 days, 75%

21 days, 65%
Absorption Profile Permanent 90 – 110 days 180 days
Sizes 3-0, 2-0, 0, 1 4-0, 3-0, 2-0 4-0, 3-0, 2-0, 0
Indications V-Loc™ PBT non-absorbable wound closure devices are indicated for soft tissue approximation. V-Loc™ 90 absorbable wound closure devices are indicated for soft tissue approximation where use of an absorbable suture is appropriate. V-Loc™ 180 absorbable wound closure devices are indicated for soft tissue approximation where use of an absorbable suture is appropriate.
Contraindications The use of the V-Loc™ PBT nonabsorbable wound closure device is contraindicated in patients with known sensitivities or allergiesThe use of the V-Loc™ PBT nonabsorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. V-Loc™ PBT nonabsorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ PBT nonabsorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ PBT nonabsorbable wound closure device should not be used for ligating vessels or luminal structures. The use of the V-Loc™ 90 absorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. The V-Loc™ 90 absorbable wound closure device is not for use where prolonged (beyond 2 weeks) approximation of tissues under stress is required or for fixation of permanent cardiovascular prostheses or synthetic grafts. V-Loc™ 90 absorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ 90 absorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ 90 absorbable wound closure device should not be used for ligating vessels or luminal structures. The use of the V-Loc™ 180 absorbable wound closure device is contraindicated in patients with known sensitivities or allergies to its components. The V-Loc™ 180 absorbable wound closure device is not for use where prolonged (beyond 3 weeks) approximation of tissues under stress is required or for fixation of permanent cardiovascular prostheses or synthetic grafts. V-Loc™ 180 absorbable wound closure device should not be used for interrupted suture patterns. V-Loc™ 180 absorbable wound closure device is not intended to be used by tying surgical knots. V-Loc™ 180 absorbable wound closure device should not be used for ligating vessels or luminal structures.
Box Quantities 1 dozen 1 dozen 1 dozen

ORDER INFORMATION

codes beginning with:

 VLOCN VLOCM VLOCL

V-Loc™ Experience Paper

Peritoneal Closure in TAPP Hernia Repair

View Experience Paper

V-Loc™ Clinical Summary

T. O. Smith, D. Sexton, C. Mann, S. Donell - Sutures versus Staples for Skin Closure in Orthopaedic Surgery: Meta-analysis

View Clinical Summary

‘Real-World’ Experiences of Surgeons using the V-Loc™ 180 Device by D. Erdmann

Results of an international survey

Learn More

Resources

CORPORATE RESOURCES
Minimally Invasive Therapies
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2021 Medtronic